VAERS 2314116
SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ749AA
- Staat
- MI
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 09.06.2022
- Impfdatum
- 27.10.2021
- Beginn
- 07.06.2022
- Tage bis Beginn
- 223,0
- Dosis
- N/A
- Route/Site
- - / -
Symptomtext
Admission Date: 6/7/2022 Discharge Date: Jun 8, 2022 PRESENTING PROBLEM: COVID-19 HOSPITAL COURSE: 66-year-old female with a past medical history significant for CML as well as self-reported history of asthma and previous COVID-19 vaccination who presents due to complaints of generalized weakness as well as headache and neck pain. Patient states he has been at her baseline state of health up until the morning of 06/06/2022. She states he has been feeling well has had no complaints that she thought were related to infection. However, after awakening 06/06/2022, she complained of generalized weakness. She states that while she normally ambulates around the house with no assistive devices although she does use a cane and walker outside the house, she felt like her legs at home today were much weaker than usual. She had no numbness or tingling. She did report a headache with some neck pain but she had no visual changes and no photophobia. With her symptoms she was concerned that she may have had a stroke and because of this, she presented to the emergency department. In the emergency department the patient was hemodynamically stable and afebrile. Low suspicion was had for a stroke based on the patient's clinical exam and she did undergo CT angiography of the head and neck as well as CT of the head unenhanced. No acute pathology was seen on imaging. However, the patient did test positive for COVID-19 and with ambulation, her oxygen saturation would drop to the mid 80% range and she would become quite tachycardic. Because of this, she was thought to warrant observation in the hospital and she was started on dexamethasone by the ER provider. in-house: patient presented with generalized weakness as well as headache and neck pain, she was admitted for acute hypoxemic respiratory failure secondary to what was suspected to be a COVID-19 mediated asthma exacerbation. patient was started on prednisone (she was given a dose of dexamethasone in the ED) and nebulizers; micro studies were sent were sent as well. a CXR was obtained and steroids were switched to dexamethasone, procalcitonin and the rest of her 'COVID labs' (d-dimer, ESR, and troponin) were unremarkable. pulmonary rehab saw her and set her up with home oxygen, suspect a component of her hypoxemia (if not all of it) is related to underlying lung disease. patient was arranged to be followed by 'Transition to Home' service. at the time of discharge patient was in good spirits and eager to leave. she said she felt slightly weak (ambulated the halls fine) and head her usual daily morning SOB. all questions and concerns addressed, all meds and follow-ups reviewed.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Hypertension Asthma exacerbation attacks Cervical spondylosis with myelopathy Carpal tunnel syndrome Esophageal reflux Iron deficiency anemia Neoplasm of uncertain behavior of other lymphatic and hematopoietic tissues Disease of white blood cells Disturbance of skin sensation Hyperlipidemia Sleep apnea Essential thrombocythemia AVN (avascular necrosis of bone) Tobacco abuse Asthma exacerbation, non-allergic, moderate persistent AVM (arteriovenous malformation) of colon Erythromelalgia Thrombocytosis Myeloproliferative disease Polyp of duodenum Neutrophilic leukocytosis Neoplasm of uncertain behavior of colon Hiatal hernia Angiodysplasia of stomach and duodenum without bleeding Essential hypertension, benign Asthma exacerbation Asthma-COPD overlap syndrome with acute exacerbation Acute upper GI bleed
- Andere Medikamente
- acetaminophen (TYLENOL) 500 MG tablet acetaminophen-codeine (TYLENOL #3) 300-30 MG per tablet albuterol (ACCUNEB) 1.25 MG/3ML nebulizer solution albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler (Expir
- Allergien
- Environmental Seafood SingulairRash Theophylline
- Vorherige Impfungen
- -